Internal Medicine, Infectious Disease · New York, NY
NPI
1760538664
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
119 W 24th St, Css - Rogers Unit
New York, NY, 10011
Phone (212) 746-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
342 services
Medicare patients, 2024
86
Average age 68
Drug cost, 2024
$4.8M
4,849 prescriptions
Company payments, 2023
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary A Vogler was code 99215 (office e&m - established), 108 times for 45 patients. In total Mary A Vogler billed 342 services in 13 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 108 | 45 | $120.82 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 101 | 43 | $14.50 | $1,464 |
| 99232 Hospital E&M - Subsequent | Facility | 41 | 23 | $73.69 | $3,021 |
| 99222 Hospital E&M - Initial | Facility | 25 | 25 | $122.52 | $3,063 |
By year: 2022 $13K for 170 services; 2023 $18K for 193 services; 2024 $26K for 342 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary A Vogler prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 387 prescriptions and refills. In total Mary A Vogler wrote 4,849 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 387 | 401 | 48 | $1.5M |
| Atorvastatin Calcium Generic | 175 | 311 | 45 | $1,206 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 169 | 185 | 17 | $673K |
| Tivicay Dolutegravir Sodium | 153 | 157 | 23 | $343K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 148 | 163 | 31 | $4,970 |
| Descovy Emtricitabine/Tenofov Alafenam | 143 | 143 | 20 | $302K |
| Amlodipine Besylate Generic | 124 | 274 | 31 | $568 |
| Valacyclovir Valacyclovir Hcl | 107 | 211 | 28 | $6,321 |
| Gabapentin Generic | 105 | 126 | 24 | $1,146 |
| Dovato Dolutegravir Sodium/Lamivudine | 99 | 107 | 14 | $307K |
| Rosuvastatin Calcium Generic | 74 | 144 | 19 | $928 |
| Tamsulosin Hcl Generic | 74 | 148 | 18 | $785 |
| Omeprazole Generic | 73 | 114 | 14 | $740 |
| Metoprolol Succinate Generic | 69 | 135 | 16 | $765 |
| Prezcobix Darunavir/Cobicistat | 66 | 66 | Under 11 | $165K |
Brand drugs: 1,951 claims; generic drugs: 2,870 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Mary A Vogler $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Shionogi Inc with $125.
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc 4507.T | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.